发明授权
US07943649B2 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors
有权
2-(苯基或杂环)-1H-吡唑并[9,10-d]咪唑,为mPGES-1抑制剂
- 专利标题: 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors
- 专利标题(中): 2-(苯基或杂环)-1H-吡唑并[9,10-d]咪唑,为mPGES-1抑制剂
-
申请号: US12288947申请日: 2008-10-24
-
公开(公告)号: US07943649B2公开(公告)日: 2011-05-17
- 发明人: Anh Chau , Bernard Cote , Yves Ducharme , Richard Frenette , Richard Friesen , Marc Gagnon , Andre Giroux , Evelyn Martins , Hongping Yu , Tom Wu
- 申请人: Anh Chau , Bernard Cote , Yves Ducharme , Richard Frenette , Richard Friesen , Marc Gagnon , Andre Giroux , Evelyn Martins , Hongping Yu , Tom Wu
- 申请人地址: CA Quebec
- 专利权人: Merck Frosst Canada Ltd.
- 当前专利权人: Merck Frosst Canada Ltd.
- 当前专利权人地址: CA Quebec
- 代理商 Valerie J. Camara; Maria V. Marucci
- 主分类号: A61K31/4184
- IPC分类号: A61K31/4184 ; A61K31/5377 ; C07D235/02 ; C07D413/14
摘要:
The invention encompasses novel compounds of Formula I or pharmaceutically acceptable salts thereof. These compounds are inhibitors of the microsomal prostaglandin E synthase-1 (mPGES-1) enzyme and are therefore useful to treat pain and/or inflammation from a variety of diseases or conditions, such as osteoarthritis, rheumatoid arthritis and acute or chronic pain. Methods of treating diseases or conditions mediated by the mPGES-1 enzyme and pharmaceutical compositions are also encompassed.
公开/授权文献
信息查询
IPC分类: